Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ: MEDP )

317.93 -6.98 (-2.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks Slip As Wall Street Eyes Earnings, Economic Data
All three major indexes are headed lower, as investors continue to unpack this morning's earnings reports. 
Via Talk Markets
Earnings Outlook For Medpace Hldgs
Via Benzinga
Medpace Hldgs's Earnings: A Preview
Via Benzinga
Why Medpace Stock Soared Today
The clinical trial specialist is winning new business at an impressive clip. 
Via The Motley Fool
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Xerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Medpace, A Top 1% Earnings Stock, Just Crushed Expectations — Here's A Key Measure To Watch
The company outperformed sales and earnings estimates and raised its outlook. 
Via Investor's Business Daily
After-Hours Alert: Why Medpace Stock Is Moving Higher
Medpace Holdings Inc (NASDAQ: MEDP) shares are moving higher in Monday's after-hours session after the contract research company reported strong first-quarter resu 
Via Benzinga
Medpace Holdings, Inc. Reports First Quarter 2023 Results
From Medpace Holdings, Inc.
Via Business Wire
Thermo Fisher Stock Sets Up In Healthy Base; Earnings Due
Thermo Fisher stock is among the top 3 in the Medical-Research Equipment/Services industry group. It got a key rating upgrade Tuesday. 
Via Investor's Business Daily
Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For April 24, 2023
Companies Reporting Before The Bell • Dynex Cap (NYSE:DX) is estimated to report quarterly earnings at $0.17 per share on revenue of $6.99 million. 
Via Benzinga
Want $1 Million in Retirement? Invest $200,000 in These 3 Stocks and Wait a Decade
A basket balanced evenly across these three businesses could jump-start your journey to becoming a millionaire. 
Via The Motley Fool
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Results
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For February 13, 2023
Companies Reporting Before The Bell • EuroDry (NASDAQ:EDRY) is expected to report quarterly earnings at $2.68 per share on revenue of $21.20 million. 
Via Benzinga
Better Healthcare Buy for 2023: Medpace Holdings or Doximity?
The healthcare stocks expect similar revenue growth in 2023. 
Via The Motley Fool
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 13, 2023
From Medpace Holdings, Inc.
Via Business Wire
Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally
UnitedHealth is among medical stocks holding key support. 
Via Investor's Business Daily
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
These 4 Superb Growth Stocks Are Beating the Nasdaq Bear Market: Is It Too Late to Buy?
There's good reason to expect these businesses to continue their histories of outperformance, regardless of market conditions. 
Via The Motley Fool
Coke's Fizz, Weber's Proposed Deal, and Stock Market Superstitions
There's a lot for investors to think about. 
Via The Motley Fool
Why Medpace Holdings Jumped 41.5% This Week
The clinical contract research organization is seeing an increase in new business. 
Via The Motley Fool
Stock Market Rally Resilient As Apple Bucks Megacap Meltdown: Weekly Review
The Dow and S&P 500 moved above a key level while the Nasdaq rose. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022
Upgrades 
Via Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Stocks Pop As "Fear Gauge" Cools Off
Stocks have shrugged off premarket losses and are confidently higher ahead of Big Tech earnings. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.